COVID-19 and ICU-acquired MDR Bacteria (COVID-BMR)

University Hospital, Lille

Status: Completed

Conditions: Sars-CoV2; Critical Illness

Study type: Observational

Funder types: Other

Identifiers

NCT04378842

2020-A01157-32 (Other Identifier)

2020_37

Details and patient eligibility

About

This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.

Full description

Multicenter observational before-after study, aiming to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to MDR bacteria.

Enrollment: 368 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Expected ICU stay > 48 hours
• Rectal and nasal BMR screening performed < 48 hours after admission to ICU

Exclusion criteria

• Patients aged < 18 years Refusal to take part in the study ICU-stay < 48 hours At least a second rectal and nasal BMR screening was not performed prior to ICU discharge (a posteriori exclusion criterion).